Using recombinant strains of Synechocastis and engineering the expression of hoxH and other hydrogenase genes, the researchers succeeded to increase the production of succinic and lactic acid from CO2 under anaerobic conditions in the dark 5- and 13-fold, reaching...
Japan will attempt to cope with his target of 32 % for emission reduction according to the 2013 Paris agreement, equivalent to 10.2 million t CO2. The present program is aimed at the reduction and substitution of halogenated refrigerants HFC through the development of...
Methuselah Co., set up in Yamagata in June 2016, has developed technology to produce autologous fibroblast cells, a cell type which which can be blended with other functional cells to develop regenerative medicine of various types. BioImpact news release, July 7,...
The hard X-ray FEL reaches 0.1 nm oscillating wavelength, whereas the soft SX-FEL beamline reaches 12 nm wavelength. The SACLA facility is the world’s only which offers both types of beamlines in parallel. RIKEN news release, July 22, 2016
The physician-led clinical trial will start 2017 at Kyushu University under Kohei SONODA on incorporating human pigment epithelium-derived factor within a therapeutic vector to human patients. 5 years of animal experiments on this procedure did indicate no problems....
